Specialty label from Schreiner MediPharm blinds vials for clinical trial

For an international Phase III study of a new immunoglobolin, CSL Behring, one of the leading international biotech companies headquartered in the US, relies on a novel label combination from Schreiner MediPharm. With a special Flexi-Cap version that completely covers the vial and a booklet-label for multilingual product information, the vials containing the drugs, according to the company, to be tested are reliably blinded. Schreiner MediPharm, a business unit of Schreiner Group based in Oberschleissheim near Munich, is a leading developer and manufacturer of innovative, multifunctional specialty labels and marking solutions with value-added benefits for the healthcare industry. The company has a production site in the United States. Products are manufactured for the North American pharmaceutical market in Blauvelt, New York. The company is represented in more than 20 countries, including India, through its network of specialists. CSL Behring uses transparent containers with a flip-off cap for the clinical trial. Due to the visible differences between the verum and the placebo, the containers with the trial drugs have to be blinded because the trial participants…

Choose your subscription to read more